PSMB10 and acute myeloid leukemia: Here, we found that the especially increased PSMB10 in non-senescent drug-resistant LSC acts as a key molecule not only for resistance to senescence induction and initiation but also for escape from CTL killing, leading to their stemness maintenance in patients with relapsed and refractory AML.